These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26234979)

  • 1. Prescription, Dispensation, and Generic Medicine Replacement Ratios: Influence on Japanese Medicine Costs.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2015 May; 8(1):29-35. PubMed ID: 26234979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the separation of prescription and dispensation of medicine on its cost in Japanese prefectures.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2014 Apr; 6(4):57-62. PubMed ID: 24999122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Community Pharmacists' Dispensing Influences Medicine Price Reduction more than Prescription Numbers.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2016 Sep; 8(9):54314. PubMed ID: 27157157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of utilization of community pharmacy generic drug discount programs.
    Gatwood J; Tungol A; Truong C; Kucukarslan SN; Erickson SR
    J Manag Care Pharm; 2011; 17(6):449-55. PubMed ID: 21787030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M; Lawson KA; Shepherd MD
    J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring economic impact of applying daily average consumption limits.
    Flavin BM; Nishida LM; Karbowicz SH; Renner ME; Leonard RJ
    J Manag Care Pharm; 2014 Feb; 20(2):159-64. PubMed ID: 24456317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older people's perceptions of prescription medicine costs and related costs: a pilot study in New Zealand.
    Tordoff J; Bagge M; Ali F; Ahmed S; Choong JN; Fu R; Joe A; Nishtala P
    J Prim Health Care; 2014 Dec; 6(4):295-303. PubMed ID: 25485325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the introduction of government use licenses on the drug expenditure on seven medicines in Thailand.
    Mohara A; Yamabhai I; Chaisiri K; Tantivess S; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S95-9. PubMed ID: 22265076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generic drug market in Japan: will it finally take off?
    Iizuka T; Kubo K
    Health Econ Policy Law; 2011 Jul; 6(3):369-89. PubMed ID: 21205400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Price difference as a predictor of the selection between brand name and generic statins in Japan.
    Takizawa O; Urushihara H; Tanaka S; Kawakami K
    Health Policy; 2015 May; 119(5):612-9. PubMed ID: 25697888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restrictions on the reimbursement policy with regard to retail marketing of medicinal products in Poland.
    Zimmermann A
    Acta Pol Pharm; 2013; 70(2):339-43. PubMed ID: 23614291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer choice between common generic and brand medicines in a country with a small generic market.
    Fraeyman J; Peeters L; Van Hal G; Beutels P; De Meyer GR; De Loof H
    J Manag Care Spec Pharm; 2015 Apr; 21(4):288-96. PubMed ID: 25803762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.